Hancock Whitney Corp United Therapeutics Corp Transaction History
Hancock Whitney Corp
- $3.07 Billion
- Q3 2024
A detailed history of Hancock Whitney Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Hancock Whitney Corp holds 5,139 shares of UTHR stock, worth $1.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,139
Previous 5,201
1.19%
Holding current value
$1.8 Million
Previous $1.66 Million
11.17%
% of portfolio
0.06%
Previous 0.06%
Shares
26 transactions
Others Institutions Holding UTHR
# of Institutions
681Shares Held
42.2MCall Options Held
194KPut Options Held
298K-
Black Rock Inc. New York, NY5.47MShares$1.92 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.55 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.11 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$786 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...